bioRxiv Science⌕ Search

Biology subjects

Gillrie, M. R.

Publications and source records attributed to Gillrie, M. R..

2 recordsLinked to original sources

On-chip engineered human lymphatic microvasculature for physio-/pathological transport phenomena studies

The human vasculature constitutes an integral part of fluid, protein and cellular transport throughout a variety of physiological processes and pathological events. While the blood vascular system has been the topic of numerous studies in connection to its role in physio-/pathological transport phenomena, our secondary vascular system, the lymphatics, has yet to gain similar attention, in part due to a lack of adequate models to study its biological function. Despite their considerable value, animal models limit the ability to perform parametric studies, whereas current in vitro systems are lacking in physiological mimicry. Here, a microfluidic-based approach is developed that allows for precise control over the transport of growth factors and interstitial fluid flow, which we leverage to recapitulate the in vivo growth of lymphatic capillaries. Using this approach, physiological tissue functionality is validated by characterizing the drainage rate of extracellular solutes and proteins. Finally, lymphatic-immune interactions are studied to affirm inflammation-driven responses by the lymphatics, which recruit immune cells via chemotactic signals, similarly to in vivo, pathological events. Results demonstrate the utility of this platform to study lymphatic biology and disease, as well as use as a screening assay to predict lymphatic absorption of therapeutic biologics.

bioengineering↗

Personalized models of breast cancer desmoplasia reveal biomechanical determinants of drug penetration

Breast cancer desmoplasia heterogeneity contributes to high disease mortality due to discrepancies in treatment efficacy between patients. Personalized in vitro breast cancer models can be used for high throughput testing and ranking of therapeutic strategies to normalize the aberrant microenvironment in a patient-specific manner. Here, tumoroids assembled from patient-derived cells cultured in microphysiological systems including perfusable microvasculature reproduce key aspects of stromal and vascular dysfunction. Increased hyaluronic acid and collagen deposition, loss of vascular glycocalyx and reduced perfusion, and elevated interstitial fluid pressure in the models result in impaired drug distribution to tumor cells. We demonstrate the application of these personalized models as tools to rank molecular therapies for the normalization of the tumoroid microenvironment and to discover new therapeutic targets such as IL8 and CD44, which may ultimately improve drug efficacy in breast cancer patients.

bioengineering↗